Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
Anaphylactic reactions were observed after Singapore’s national coronavirus disease 2019 (COVID-19) vaccination programme started in December 2020. We report the clinical and laboratory features of three patients in our institution who developed anaphylactic reactions after receiving the Pifzer BNT1...
Main Authors: | Xin Rong Lim, Bernard Pui Leung, Carol Yee Leng Ng, Justina Wei Lynn Tan, Grace Yin Lai Chan, Chien Mei Loh, Gwendolyn Li Xuan Tan, Valerie Hui Hian Goh, Lok To Wong, Chong Rui Chua, Sze Chin Tan, Samuel Shang Ming Lee, Hwee Siew Howe, Bernard Yu Hor Thong, Khai Pang Leong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/9/974 |
Similar Items
-
Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech
by: Yusuke Okada, et al.
Published: (2021-09-01) -
Bibliometric Analysis of Pfizer-BioNTech (BNT162B2): A COVID-19 Vaccine
by: Waseem Hassan, et al.
Published: (2021-09-01) -
Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
by: Yohhei Hamada
Published: (2021-08-01) -
Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine
by: Hiroaki Akiyama, et al.
Published: (2021-01-01) -
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
by: Cohen, K., et al.
Published: (2022)